Healthcare -
Biotechnology - NASDAQ - US
$ 6.43
-2.43 %
$ 2.47 B
Market Cap
-3.8
P/E
RXRX - PRE-TAX INCOME
Pre-tax Income RXRX - Recursion Pharmaceuticals, Inc.
-332 M
LAST VALUE
-33.46%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR